Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00676585 · ClinicalTrials.gov registry record · Phase 1
Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest
A Phase 1 study of Cardiac Arrest, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT00676585: Completed Phase 1 study of Cardiac Arrest, sponsored by Beth Israel Deaconess Medical Center.
NCT00676585 is a Phase 1 study of Cardiac Arrest that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 50 participants, below the 1,478-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00676585, a Phase 1 study of Cardiac Arrest, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The major goal of this project is to determine whether the use of physiologic doses of corticosteroids will decrease time to shock reversal, alters the inflammatory cascade, and alters microcirculatory flow in post-cardiac arrest patients.
Primary Outcome
The primary outcome was time to shock reversal defined as at least 24 hours off all vasopressor medications.
Conditions Studied
Interventions
- DRUG Hydrocortisone
- DRUG Normal Saline
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2007-10 |
| Est. Completion | 2014-04 |
| Phase | Phase 1 |
What the finished NCT00676585 record still lists
NCT00676585 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,478-participant average among 31 other Cardiac Arrest trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Cardiac Arrest appearing as the primary indexed condition, and to 2 interventions - of which Hydrocortisone is the first listed.
NCT00676585 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00676585 about?
NCT00676585 is a clinical study titled "Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest". The major goal of this project is to determine whether the use of physiologic doses of corticosteroids will decrease time to shock reversal, alters the inflammatory cascade, and alters microcirculatory flow in post-cardiac arrest patients.
What is the current status of trial NCT00676585?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 50 participants. The study started on 2007-10. Estimated completion is 2014-04.
What conditions does trial NCT00676585 study?
This clinical trial studies the following conditions: Cardiac Arrest.
What interventions are being tested in trial NCT00676585?
The interventions under investigation include: Hydrocortisone (DRUG), Normal Saline (DRUG).
Who is sponsoring clinical trial NCT00676585?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00676585 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Arrest
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00676585's enrollment target sits among peer trials
50 20th of 31 higher than 10 of 31 other Cardiac Arrest trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiac Arrest trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post-CA Neuroprotection With Magnesium
RECRUITING · Phase 1
-
Hydrogen's Feasibility and Safety as a Therapy in ECPR
RECRUITING · Phase 1
-
Packed Red Blood Cell Transfusion During Cardiac Arrest
RECRUITING · Phase 1
-
Washington Study of Hemofiltration After Out-of-Hospital Cardiac Arrest
COMPLETED · Phase 1
-
Trial of Vasopressin and Epinephrine to Epinephrine Only for In-Hospital Pediatric Cardiopulmonary Resuscitation
COMPLETED · Phase 1
-
Reoxygenation After Cardiac Arrest II (REOX II Study)
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia